Chromosome 9p syndrome is a rare chromosomal abnormality caused by a partial deletion in chromosome 9. It was first described in 1973 by Alfi et al., and has since been shown to have diverse clinical phenotypes. Here, we reported a case of a male infant with joint contracture of the extremities, dysmorphic face, inguinal hernia, and testicular cystic masses. Chromosomal analysis revealed a terminal deletion at the short arm of chromosome 9. The major clinical features of the 9p deletion syndrome are trigonocephaly, small palpebral fissures, a flat nasal bridge, and mental retarda tion. To the best of our knowledge, this is the first reported case of a patient with 9p24 deletion presenting with arthrogryposis multiplex congenita.
INTRODUCTION
The chromosome 9p deletion syndrome was first reported in 1973 by Alfi et al. 1) , and has since been reported worldwide. It is caused by the partial deletion of the short arm of chromosome 9, and is clinically characterized by trigonocephaly with a prominent forehead, small palpebral fissures, a flat nasal bridge, posteriorly angulated ears, micro gnathia, anteverted nostrils, a long philtrum, and hypotonia 2, 3) . In some cases, congenital malformations such as cardiac defects, inguinal hernia, omphalocele, and choanal atresia have been found 4) . The clinical manifestations of this syndrome are diverse, and depend on the extent and location of the deletion.
Patients who have the 9p deletion as well as the 46, XY chromosomal disorder have shown abnormal sexual development 5, 6) . The gonadal phenotype appears in the form of complete gonadal dysgenesis, hypospadias, cryptorchidism, and/or gonadoblastoma 7, 8) .
The external genital expression varies from complete female to male with hypospadias 6, 9) . Abnormal muscle tone, mainly hypohonia, has been observed in some patients with the 9p24 deletion syndrome 10) . However, arthrogryposis multiplex congenita (AMC) has not been reported in any case of 9p24 deletion. AMC is characterized by contractures in more than two joints, and is thought to be caused by both genetic and environmental factors 11) . To the best of our knowledge, this is the first reported case of a patient with 9p24 deletion presenting with AMC.
CASE REPORT
A male neonate with contracture of both extremities was admitted at our center for evaluation and management on the second day after birth. He was born at full term from non Tumor markers were analyzed to rule out tumorous conditions. Serum alphafetoprotein level was 1,162 ng/mL, and beta human chorionic gonadotropin level was 1.2 mIU/mL. As the possibility of a malignancy was considered low, the decision was made for the patient to undergo observations and follow up at an outpatient clinic. When the patient was 58 days old, the splint treatment was deemed no longer necessary, and only the stretching exercises were continued. Because growth retardation, developmental delay, and cognitive impairment are common in patients with 9p terminal deletion syndrome, he is undergoing close developmental evaluation.
DISCUSSION
The phenotypes observed in this case were consistent with those of other previously reported patient with 9p deletion syndrome 6, 7, 12) . In addition, our patient showed symptoms of AMC, which have not previously been reported in patients with de novo 9p deletion syndrome. Various studies have reported that 9p deletion syndrome is caused by a partial monosomy of 9p, with breakpoint sites mainly in the regions 9p22 to 9p24 5) .
In this case, deletion of regions 9p22.3 to 9p24 was confirmed by chromosomal microarray. This region contains many critical genes, including DMRT13, DOCK8, KANK1, SMARCA2, VLDLR, KCNV2, GLIS3, SLC1A1, JAK2, GLDC, TYRP1, CER1, and MPDZ (OMIM).
Haploinsufficiency of the sexdetermining genes, DMRT1
and 2, which are located on 9p24.3, and other genetic defects are likely associated with the abnormal sexual development 10) .
DMRT1 activates testisspecific genes such as Sox9 and Sox8, and represses ovaryspecific genes encoding Fox12, Wnt4 and Rspondin1 signaling proteins, and estrogen receptors 2, 5, 7) . CER1
has been proposed as a candidate gene responsible for dysmor 
